Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study).
Dib N, Dinsmore J, Lababidi Z, White B, Moravec S, Campbell A, Rosenbaum A, Seyedmadani K, Jaber WA, Rizenhour CS, Diethrich E. Dib N, et al. Among authors: campbell a. JACC Cardiovasc Interv. 2009 Jan;2(1):9-16. doi: 10.1016/j.jcin.2008.11.003. JACC Cardiovasc Interv. 2009. PMID: 19463392 Free article. Clinical Trial.
Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.
Dib N, Michler RE, Pagani FD, Wright S, Kereiakes DJ, Lengerich R, Binkley P, Buchele D, Anand I, Swingen C, Di Carli MF, Thomas JD, Jaber WA, Opie SR, Campbell A, McCarthy P, Yeager M, Dilsizian V, Griffith BP, Korn R, Kreuger SK, Ghazoul M, MacLellan WR, Fonarow G, Eisen HJ, Dinsmore J, Diethrich E. Dib N, et al. Among authors: campbell a. Circulation. 2005 Sep 20;112(12):1748-55. doi: 10.1161/CIRCULATIONAHA.105.547810. Circulation. 2005. PMID: 16172284
Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy.
Dib N, McCarthy P, Campbell A, Yeager M, Pagani FD, Wright S, MacLellan WR, Fonarow G, Eisen HJ, Michler RE, Binkley P, Buchele D, Korn R, Ghazoul M, Dinsmore J, Opie SR, Diethrich E. Dib N, et al. Among authors: campbell a. Cell Transplant. 2005;14(1):11-9. doi: 10.3727/000000005783983296. Cell Transplant. 2005. PMID: 15789658 Free article. Clinical Trial.
A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease.
Fuchs S, Dib N, Cohen BM, Okubagzi P, Diethrich EB, Campbell A, Macko J, Kessler PD, Rasmussen HS, Epstein SE, Kornowski R. Fuchs S, et al. Among authors: campbell a. Catheter Cardiovasc Interv. 2006 Sep;68(3):372-8. doi: 10.1002/ccd.20859. Catheter Cardiovasc Interv. 2006. PMID: 16892433 Clinical Trial.
A percutaneous swine model of myocardial infarction.
Dib N, Diethrich EB, Campbell A, Gahremanpour A, McGarry M, Opie SR. Dib N, et al. Among authors: campbell a. J Pharmacol Toxicol Methods. 2006 May-Jun;53(3):256-63. doi: 10.1016/j.vascn.2005.10.005. Epub 2006 Feb 7. J Pharmacol Toxicol Methods. 2006. PMID: 16460969
A framework for monitoring RSV prevention product effectiveness in the United States.
Roper LE, Link-Gelles R, Surie D, DeCuir J, Zambrano LD, Prill MM, Havers FP, Jones JM, Melgar M, Hall AJ, Whitehead RD Jr, McMorrow ML, Ioannou GN, Hernandez-Romieu AC, Britton A, Novosad S, Martin A, Feldstein LR, Bajema KL, Kirking H, Moline H, Campbell AP, Aslan M, Hatfield K, Dawood F, Slayton R, Reddy S, Gomes D, Fleming-Dutra KE, Payne AB. Roper LE, et al. Among authors: campbell ap. Vaccine. 2025 Jan 2;45:126633. doi: 10.1016/j.vaccine.2024.126633. Online ahead of print. Vaccine. 2025. PMID: 39755055
5,292 results